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Abstract Ultraviolet A (UVA: 320-400 nm) radiation activates 
c-Jun-N-terminal kinase (JNK 2) in human skin fibroblasts. 
Exposure of cells to UVA (300 kj/m2) led to a 5-fold induction 
of JNK-activity which was significantly increased in the presence 
of D 2 0 , an enhancer of the lifetime of singlet oxygen. Sodium 
azide, a quencher of singlet oxygen, abolished the activation of 
JNK. A hydroxyl radical scavenger, mannitol, had no effect. 
Furthermore, photochemically produced singlet oxygen (Rose 
Bengal plus white light) was found to induce JNK activity. This 
was enhanced by D 2 0 and inhibited by azide. Thus, singlet 
oxygen activates and mediates the UVA-induced activation of 
JNK. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Singlet molecular oxygen (102) can be produced in biolog-
ical systems by photoexcitation (Type II reactions) upon ex-
posure of endogenous photosensitisers, such as flavins, qui-
ñones or porphyrins to ultraviolet A (UVA) [1], or by chemi-
excitation [2,3]. Apart from being involved in the damaging 
effects of UVA radiation (32CM-00 nm) on cellular systems 
[4,5], 1 0 2 modulates gene expression and herein mimics 
UVA radiation: Heme oxygenase-1 (HO-1) [6,7], interstitial 
collagenase (matrix metalloproteinase-1) [8,9], and intercellu-
lar adhesion molecule-1 (ICAM-1) [10] have been demon-
strated to be induced by UVA and singlet oxygen that was 
produced either chemically by the thermodecomposition of 
NDP0 2 (the 1,4-endoperoxide of 3,3'-(l,4-naphthylidene) di-
propionate) or photochemically. 
Regarding the UVA or 1C>2-mediated signalling pathways 
leading to gene expression, the induced expression of ICAM-1 
is mediated by activated transcription factor AP-2, but not 
AP-1 or NF-κΒ, in human keratinocytes [10]. Interrelated 
autocrine loops with the interleukins IL-1 and IL-6 being in-
volved were made responsible for the induction of collagenase 
in human skin fibroblasts [11]. Additionally, NF-κΒ was re-
cently shown to be activated in fibroblasts upon UVA treat-
ment [12]. 
It is well established that short-wavelength ultraviolet radi-
ation (UVC or UVB) induces the so-called UV response com-
prising the induction of immediate-early genes such as c-jun 
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and c-fos [13]. The induced expression of these genes follows 
the activation of transcription factors that are phosphorylated 
by members of the MAPK family: upon activation by dual 
phosphorylation of a Thr*-Pro-Tyr* motif, c-Jun-N-terminal 
kinases (JNK; also termed stress-activated protein kinases, 
SAPK [14]), phosphorylate c-Jun [15,16], activating transcrip-
tion factor-2 (ATF-2) [17], and Elk-1 [18]. JNKs have been 
demonstrated to be activated by UVC ( < 280 nm) [16,19] and 
UVB (280-320 nm) [[20], P. Brenneisen et a l , unpublished 
results] irradiation in a variety of cells, a possible exception 
being keratinocytes where JNKs seem to respond to UVC but 
not UVB [19]. 
Here we report the activation of c-Jun-N-terminal kinase 2 
by UVA radiation which is the major part of the UV region 
of the solar spectrum that reaches the earth and by singlet 
oxygen which seems to mediate the UVA effects. 
2. Materials and methods 
2.1. Cell culture and cell viability assays 
Human skin fibroblasts from foreskin biopsies were cultured in 
Dulbecco's modified Eagles medium (DMEM) supplemented with 
10% fetal calf serum, 2 mM L-glutamine, streptomycin (0.02 g/1), 
penicillin (20000 IU/1), and ascorbate (50 mg/1). Cell viabilities were 
determined by measuring the ability of cells to produce a blue-colored 
formazan from the tetrazolium salt MTT (3-[4,5-dimethyl-thiazol-2-
yl]-2,5-diphenyltetrazolium bromide). 
2.2. Singlet oxygen and UVA sources 
Singlet oxygen was produced by irradiating solutions containing 
varying concentrations of Rose Bengal (RB) for 10 min with a com-
mercially available 500 W lamp from a fixed distance of 66 cm. UVA 
irradiations were performed at intensities of 42-44 mW/cm2 for ap-
proximately 12 min (yielding a dose of 300 kJ/m2) using a UVA700 
illuminator from Waldmann (Villingen, Germany). For treatments in 
the presence of deuterium oxide (90%), 10 X concentrated PBS was 
diluted in D20 (99.9%>; Sigma, Munich, Germany). 
2.3. Determination of singlet oxygen 
The production of singlet oxygen from RB+light was determined by 
the amount of endoperoxide (EAS02) formed from anthracene-9,10-
diyldiethyl disulfate (EAS) which was incubated with the irradiated 
RB solutions. EASO2 was then assayed by reversed-phase HPLC [21]. 
Furthermore, the bleaching of 4-nitroso-Ar,#-dimethylaniline (RNO) 
was used to estimate 1 0 2 production by RB+light [22,23]. 
2.4. Immunocomplex kinase assay 
Skin fibroblasts were grown to approximately 70-80% confluency in 
60 mm dishes, washed twice with phosphate-buffered saline (PBS) and 
incubated with serum-free medium for an additional 2 days; the se-
rum-free medium was renewed once. Following the removal of me-
dium and a wash step with PBS, the serum-starved cells were irradi-
ated in PBS or in PBS containing additives. After irradiation, the cells 
were covered with serum-free medium, incubated at 37°C for 30 min, 
washed with PBS of room temperature and lysed with 300 μΐ of ice-
cold RIPA-buffer (50 mM Tris (pH 8.0), 150 mM NaCl, 1 mM DTT, 
0.5 mM EDTA, 1% (w/v) Nonidet P-40 (Sigma, St. Louis, MO), 0.5% 
(w/v) sodium desoxycholate, 0.1% (w/v) SDS, 0.2 mM Na3V04, 
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
P / /S0014-5793(97)00440-7 
290 L.-0. Klotz et allFEBS Letters 408 (1997) 289-291 
Fig. 1. Induction of c-Jun-N-terminal kinase activity (as assayed via 
phosphorylation of GST-cJun(l-79)) by various doses of UVA irra-
diation of human skin fibroblasts in the presence and absence of 
deuterium oxide. 
0.8 mM PMSF, 1 μ§/piι1 aprotinin, 2 μίξ/ηιΐ leupeptin). The lysed cells 
were scraped off and centrifuged. The protein content was determined 
using a commercially available protein assay (BioRad DC-Protein 
Assay). C-Jun-N-terminal kinase 2 (JNK 2) was immunoprecipitated 
for 2-3 h on ice from cell lysates (50 μg of protein in a total volume of 
200 μΐ RIPA lysis buffer) using 10 μΐ of an anti-SAPK 2 antiserum 
(rabbit, diluted 1:10 in distilled water) which was a generous gift from 
Dr. Peter E. Shaw (Dept. of Biochemistry, University of Nottingham, 
UK). 
Immune complexes were collected at 4°C overnight with 30 μΐ of 
Protein A Sepharose 6MB (Pharmacia, Freiburg, Germany) pre-equi-
librated in RIPA lysis buffer. The pelleted immune complex/Protein A 
conglomerate was washed with both ice-cold RIPA buffer and kinase 
buffer (10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 10 mM MgCl2, 0.5 
mM DTT) 3 times each. 
Kinase buffer (35 μΐ) was added to the pellets, followed by 5 μΐ of 
150 μΜ ATP, 6 μΐ (6 μg) of GST-cJun(l-79) (Alexis, Grünberg, 
Germany) [15], and 5 μΐ (5 μθ) of [f 2P]ATP (5 Ci/μηιοΐ). The mix-
tures were incubated at 37°C for 25 min and repeatedly vortexed 
during this incubation time. 
The reaction was stopped by the addition of gel loading buffer and 
denaturation for 5 min at 95°C. The samples were centrifuged for 
2 min, and the supernatants analysed by electrophoresis on a 15% 
SDS-polyacrylamide gel. The phosphorylated JNK substrate (GST-
Fig. 3. Activation of JNK by singlet oxygen generated by RB+light; 
effects of deuterium oxide and sodium azide. Data are mean values 
of two experiments. 
cJun(l-79); 37 kDa) was identified by autoradiography and quanti-
fied by Phosphorlmager® analysis. 
3. Results and discussion 
C-Jun-N-terminal kinase ( JNK 2) activity was enhanced by 
U V A irradiation (Fig. 1). A pronounced effect was observed 
at a dose of 100 kJ/m2 (3-fold activation of J N K ) and at 300 
kJ/m2 (5-fold activation), respectively (Figs. 1 and 2). The 
activation of J N K was substantially increased in the presence 
of deuterium oxide ( ~ 13-fold), an enhancer of the lifetime of 
singlet oxygen. Furthermore, quenchers of singlet oxygen, 
such as azide (at 10 m M ) and imidazole (at 20 m M , not 
shown), inhibited the increase in J N K activity induced by 
U V A irradiation (Fig. 2). Because hydroxyl radicals can be 
produced upon U V A irradiation in a Type I photodynamic 
reaction, the effect of the hydroxyl radical scavenger mannitol 
was tested; at 40 m M it had no effect. To test whether singlet 
oxygen generated in a model system is capable of inducing 
J N K activity, we used a known photosensitising system, R B 
plus light. Under the given conditions, singlet oxygen was 
produced at a rate of 22 μΜ/min and 103 μΜ/min upon 
irradiation of 0.3 μ Μ and 1 μ Μ RB, respectively. J N K activ-
ity was markedly enhanced by RB+light ( « 5 - 6 - f o l d ; Fig. 3). 
Fig. 2. Activation of JNK by UVA, enhancement by deuterium ox-
ide and inhibition by azide. Values are means ± SEM (« = 3-6); data 
for mannitol: mean value of two experiments. 
Table 1 
Modulation of JNK activation after fibroblast exposure to UVA or 
RB+light by Ό 2 enhancer and quencher 
Additive 
None 
D 2 0 (90%) 
N 3 -
 b 




2.6 ± 0.3 







n.d. = not determined. 
aJNK activities after UVA irradiation (300 kJ/m2) or exposure to RB 
(0.3 μΜ) +light of fibroblasts were set to 1. Values are given as means 
± SEM (n = 3-6) or means of two experiments (mannitol and 
RB + light). 
bAzide concentrations were 20 mM (UVA) or 50 mM (RB + light); 
RB concentration in the azide inhibition experiment was 1 μΜ. 
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Fig. 4. Proposed scheme for the action of UVA via singlet oxygen 
affecting gene expression. 
Again, D 2 0 acted as an enhancer of JNK stimulation ( « 1 3 -
fold activation) and azide (50 mM) inhibited by 55%. These 
observations support the hypothesis of singlet oxygen involve-
ment in the activation of JNK in human dermal fibroblasts by 
UVA. The modulation of UVA-induced JNK activation by 
D 2 0 , azide and mannitol is documented in Table 1. 
The correlation between UVA and singlet oxygen has al-
ready been made for the induced synthesis of both mRNA 
and protein of heme oxygenase-1 [6,7], collagenase (MMP-1) 
[8,9] and ICAM-1 [10]. The effects of UVA irradiation have 
been attributed to 1C>2 and can be simulated employing chem-
ical and photochemical singlet oxygen sources. And vice ver-
sa, as various conditions of oxidative nature, such as the in-
duction of oxidative metabolism in the liver of mice by 
injection of carbon tetrachloride [24], are now known to acti-
vate JNKs, we here specify singlet oxygen as one of the caus-
ative oxidative species. 
It seems that singlet oxygen discriminatingly activates JNK 
but not ERK 1 or ERK 2, as RB+light could not be shown to 
effect a phosphorylation-induced shift in electrophoretic mo-
bility of ERK 1 or 2 [F. Schliess et al., unpublished work]. 
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Finally, the activation of JNKs by singlet oxygen and upon 
UVA irradiation suggests a role of transcription factor AP-1 
[16] in the intracellular signalling processes induced in skin 
fibroblasts; in fact, the activation of AP-1 in human kerati-
nocytes and fibroblasts after UVA irradiation has been docu-
mented [25]; a scheme outlining the proposed action of UVA 
and 1C>2 is shown in Fig. 4. 
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